Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis

The Biology of ST2: The International ST2 Consensus Panel

(2015) Domingo A. Pascual-Figal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

(2014) Pia Moinzadeh et al.   ANNALS OF THE RHEUMATIC DISEASES

IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy

(2014) Corinne Cayrol et al.   CURRENT OPINION IN IMMUNOLOGY

Interleukin 33: a switch-hitting cytokine

(2014) Daniel O Villarreal et al.   CURRENT OPINION IN IMMUNOLOGY

Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels

(2014) Serena Vettori et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease

(2014) CZ Camargo et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma

(2014) Dominik Bergis et al.   Translational Oncology

Interleukin-33 Potentiates Bleomycin-Induced Lung Injury

(2013) Irina G. Luzina et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin

(2013) Allison L Mathes et al.   ANNALS OF THE RHEUMATIC DISEASES

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

A Role for Soluble ST2 in Vascular Remodeling Associated with Obesity in Rats

(2013) Ernesto Martínez-Martínez et al.   PLoS One

Brief Report: Lysyl Oxidase Is a Potential Biomarker of Fibrosis in Systemic Sclerosis

(2013) Doron Rimar et al.   Arthritis & Rheumatology

Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis

(2012) Sarah Terras et al.   ANNALS OF THE RHEUMATIC DISEASES

Interleukin-33 and the function of innate lymphoid cells

(2012) Ananda S. Mirchandani et al.   TRENDS IN IMMUNOLOGY

Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement

(2011) M. Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

Timing of transition between capillaroscopic patterns in systemic sclerosis

(2011) Alberto Sulli et al.   ARTHRITIS AND RHEUMATISM

Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

(2011) Koichi Yanaba et al.   CLINICAL RHEUMATOLOGY

IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+T cells

(2011) Qianting Yang et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF- B To Dampen NF- B-Stimulated Gene Transcription

(2011) S. Ali et al.   JOURNAL OF IMMUNOLOGY

Diagnosis and Classification of Systemic Sclerosis

(2010) Eric Hachulla et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia

(2010) A. L. Herrick et al.   RHEUMATOLOGY

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

(2009) M. Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

IL-33 Induces IL-13-Dependent Cutaneous Fibrosis

(2009) A. L. Rankin et al.   JOURNAL OF IMMUNOLOGY